Doug Hampton

Ascentage Pharma’s Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug

by

SUZHOU, China and ROCKVILLE, Md., May 30, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has recommended olverembatinib (HQP1351), Ascentage Pharma’s lead novel … Read more

Sector is Expected to Reach $33.4 Billion by 2030 at a CAGR of 11.2%

by

DUBLIN, May 30, 2023 /PRNewswire/ — The “Dermatology Diagnostic Devices Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to  ResearchAndMarkets.com’s offering. The global dermatology diagnostic devices market is expected to grow at a CAGR of around 11.2% to reach $33.4 billion by 2030 from $15.88 billion in 2023. Companies Mentioned … Read more

Increasing Consumption of Dairy Products Bolsters Growth

by

DUBLIN, May 30, 2023 /PRNewswire/ — The “FMD Vaccine Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War” report has been added to  ResearchAndMarkets.com’s offering. The global FMD Vaccine Market is expected to grow at a CAGR of around 8.3% during 2023-2030. Companies Mentioned Agrovet Co., Bayer AG … Read more

Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange

by

VANCOUVER, BC, May 30, 2023 /PRNewswire/ – Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that it has engaged Aegis Capital Corporation (“Aegis”), a New York-based investment bank, as underwriter agent for a proposed listing on the NASDAQ Stock Exchange (the “Offering”). The Offering is … Read more

Cybeats Signs Trial License with Top-5 Global Medical Device Manufacturer

by

TORONTO, May 30, 2023 /PRNewswire/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) (OTCQB: CYBCF) is pleased to announce a trial license agreement for SBOM Studio1 with a Top-5 global medical device company, marking its 3rd engagement from the Medical Device Manufacturing (“MDM”) Global Top-10. “The interest from yet another global leader from the … Read more

Emergence of PCR as a Preferred COVID-19 Detection Method Benefits Demand for Associated Lab Consumables

by

DUBLIN, May 30, 2023 /PRNewswire/ — The “Lab Consumables – Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. Global Lab Consumables Market to Reach $17.2 Million by 2030 In the changed post COVID-19 business landscape, the global market for Lab Consumables estimated at US$12.1 Million in the year 2022, is projected to … Read more

Thorne HealthTech to Participate in TD Cowen’s 7th Annual Future of the Consumer Conference on June 7

by

NEW YORK, May 30, 2023 /PRNewswire/ — Thorne HealthTech, Inc. (“Thorne”) (the “Company”) (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in TD Cowen’s 7th Annual Future of the Consumer Conference in New York City. On Wednesday, June 7, at 10:45 a.m. … Read more

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

by

ANDOVER, Mass., May 30, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 24, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 87,472 shares of its common stock and … Read more

Healthcare Reforms and Government Initiatives Drive Growth

by

DUBLIN, May 30, 2023 /PRNewswire/ — The “Long-term Care Software Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to  ResearchAndMarkets.com’s offering. The global long-term care software market is expected to grow at a CAGR of around 10.7% to reach $9.67 billion by 2030 from $4.76 billion in 2023. Companies Mentioned  … Read more

Dynavax to Present at Upcoming Investor Conferences

by

EMERYVILLE, Calif., May 30, 2023 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the following upcoming investor conferences during the month of June: William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6 at 9:20 a.m. CT Goldman Sachs … Read more